A phase II study of pemetrexed in children with recurrent malignancies (COG ADVL 0525).
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Pemetrexed (Primary)
- Indications Brain cancer; Ewing's sarcoma; Glioma; Medulloblastoma; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Solid tumours
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- Sponsors Eli Lilly and Company
- 03 Mar 2010 Actual number of patients (75) added as reported by ClinicalTrials.gov record.
- 03 Mar 2010 Actual number of patients (75) added as reported by ClinicalTrials.gov record.
- 03 Mar 2010 Actual end date (1 Feb 2010) added as reported by ClinicalTrials.gov record.